摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 1170666-11-1

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
1170666-11-1
化学式
C22H39N7O5Si2
mdl
——
分子量
537.767
InChiKey
YNMJPSQWQCDISY-LIWAJOSJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.43
  • 重原子数:
    36.0
  • 可旋转键数:
    7.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.77
  • 拓扑面积:
    160.25
  • 氢给体数:
    2.0
  • 氢受体数:
    9.0

反应信息

  • 作为反应物:
    描述:
    四丁基氟化铵 作用下, 以 四氢呋喃 为溶剂, 反应 1.5h, 以87%的产率得到4'-azidoinosine
    参考文献:
    名称:
    The application of the phosphoramidate ProTide approach confers micromolar potency against Hepatitis C virus on inactive agent 4′-azidoinosine: Kinase bypass on a dual base/sugar modified nucleoside
    摘要:
    Novel phosphoramidate ProTides derived from 4'-azidoinosine have been prepared and evaluated in the replicon assay against hepatitis C Virus (HCV). The parent nucleoside analogue is inactive in this assay, while the ProTides are active at low mu M levels in some cases. This is a rare example of an inosine nucleoside analogue with potent antiviral activity and further supports the notion of ProTides as a drug discovery motif. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.03.138
  • 作为产物:
    描述:
    叠氮基三甲基硅烷四氯化锡 作用下, 以 二氯甲烷 为溶剂, 生成
    参考文献:
    名称:
    The application of the phosphoramidate ProTide approach confers micromolar potency against Hepatitis C virus on inactive agent 4′-azidoinosine: Kinase bypass on a dual base/sugar modified nucleoside
    摘要:
    Novel phosphoramidate ProTides derived from 4'-azidoinosine have been prepared and evaluated in the replicon assay against hepatitis C Virus (HCV). The parent nucleoside analogue is inactive in this assay, while the ProTides are active at low mu M levels in some cases. This is a rare example of an inosine nucleoside analogue with potent antiviral activity and further supports the notion of ProTides as a drug discovery motif. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.03.138
点击查看最新优质反应信息